Bayer's New Tactic In Roundup Settlement Talks

Bayer's New Tactic In Roundup Settlement Talks

Introduction

Bayer’s Attorney general is trying to settle all the U.S. lawsuits over their Roundup weedkiller causing cancer, and while doing so, the company is looking forward to making a proposal that will prevent the plaintiffs' lawyers from advertising for new clients.

Bayer is looking forward to resolving the litigation as it has hit its share price since it acquired Roundup as part of its $63 billion takeover of Monsanto in 2018. The company has even denied the claims that Roundup or its active ingredient glyphosate causes cancer by mentioning that the decade-old studies have certified the product of being safe.

As per the sources, Bayer is eager to consider the agreement of banning advertisements against them as it will control the company’s future legal exposure.

According to sources, Bayer is considering stopping retail sales of glyphosate while continuing to sell it to the farmers, as more number of plaintiff are private users. The company has even denied putting a cancer warning on their product as the U.S. The Environmental Protection Agency has certified it to be safe.

Last year in October, Bayer blamed law firms that their TV ad campaigns resulted in doubling U.S. plaintiff seeking damages to 42,700 within just three months.

There are more than 40,000 lawsuits filed against Roundup across the United States. All these lawsuits are consolidated before U.S. District Judge Vince Chhabria under federal multi-district litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.